Cogent Biosciences (COGT) Income towards Parent Company (2017 - 2020)
Historic Income towards Parent Company for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.4 million.
- Cogent Biosciences' Income towards Parent Company fell 59478.49% to -$11.4 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$11.4 million, marking a year-over-year increase of 8334.77%. This contributed to the annual value of -$82.1 million for FY2020, which is 15713.7% down from last year.
- Latest data reveals that Cogent Biosciences reported Income towards Parent Company of -$11.4 million as of Q4 2020, which was down 59478.49% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' Income towards Parent Company's 5-year high stood at $2.3 million during Q4 2019, with a 5-year trough of -$57.2 million in Q3 2020.
- For the 4-year period, Cogent Biosciences' Income towards Parent Company averaged around -$10.9 million, with its median value being -$8.0 million (2018).
- Per our database at Business Quant, Cogent Biosciences' Income towards Parent Company soared by 12676.83% in 2019 and then crashed by 59478.49% in 2020.
- Cogent Biosciences' Income towards Parent Company (Quarter) stood at -$6.8 million in 2017, then decreased by 26.77% to -$8.6 million in 2018, then skyrocketed by 126.77% to $2.3 million in 2019, then plummeted by 594.78% to -$11.4 million in 2020.
- Its Income towards Parent Company was -$11.4 million in Q4 2020, compared to -$57.2 million in Q3 2020 and -$7.4 million in Q2 2020.